• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

Recent Advances in the Application of (S)-2,2'-Dihydroxy-1,1'-binaphthalene-3,3'-diboronic acid (CAS: 957111-27-2) in Chemical Biology and Pharmaceutical Research

The compound (S)-2,2'-Dihydroxy-1,1'-binaphthalene-3,3'-diboronic acid (CAS: 957111-27-2) has emerged as a pivotal molecule in chemical biology and pharmaceutical research due to its unique structural and functional properties. Recent studies have highlighted its potential as a versatile building block for asymmetric synthesis, chiral recognition, and targeted drug delivery systems. This research brief synthesizes the latest findings on this compound, focusing on its applications in medicinal chemistry and biotechnology.

One of the most significant advancements involves the use of (S)-2,2'-Dihydroxy-1,1'-binaphthalene-3,3'-diboronic acid as a chiral ligand in catalytic asymmetric reactions. Researchers have demonstrated its efficacy in facilitating enantioselective transformations, such as the Suzuki-Miyaura cross-coupling reaction, which is critical for the synthesis of complex bioactive molecules. The boronic acid functional groups in this compound enable precise control over stereochemistry, making it invaluable for the production of enantiomerically pure pharmaceuticals.

In addition to its role in catalysis, this compound has shown promise in the development of biosensors and diagnostic tools. Its ability to form stable complexes with diols and other biologically relevant molecules has been exploited for glucose sensing and other biomarker detection applications. Recent studies have optimized the binding affinity and selectivity of (S)-2,2'-Dihydroxy-1,1'-binaphthalene-3,3'-diboronic acid, paving the way for its integration into next-generation diagnostic platforms.

Another groundbreaking application is in targeted drug delivery systems. The boronic acid moieties of this compound can interact with cell surface glycans, enabling the selective delivery of therapeutic agents to specific tissues or cell types. Preclinical studies have demonstrated its potential in enhancing the efficacy of anticancer drugs while minimizing off-target effects. Researchers are now exploring its use in combination therapies and personalized medicine approaches.

Despite these promising developments, challenges remain in the large-scale synthesis and stability of (S)-2,2'-Dihydroxy-1,1'-binaphthalene-3,3'-diboronic acid. Recent efforts have focused on improving synthetic routes and derivatization strategies to enhance its practicality for industrial applications. Advances in green chemistry and continuous flow synthesis are expected to address these limitations in the near future.

In conclusion, (S)-2,2'-Dihydroxy-1,1'-binaphthalene-3,3'-diboronic acid (CAS: 957111-27-2) represents a multifaceted tool in chemical biology and pharmaceutical research. Its applications span from asymmetric catalysis to biosensing and targeted drug delivery, underscoring its versatility and potential for transformative impact. Continued research and development efforts are essential to fully unlock its capabilities and translate these findings into clinical and industrial applications.

• 957111-26-1(2,2'-Bis(MOMoxy)-1,1'-binaphthyl-3,3'-diyldiboronic acid)
• 259209-23-9(Boronic acid,(2-hydroxy-3,5-dimethylphenyl)- (9CI))
• 220204-00-2((S)-2,2'-Dimethoxy-1,1'-binaphthalene-3,3'-diboronic acid)
• 459423-16-6((4-methoxy-3-phenylphenyl)boronic acid)
• 209906-19-4(Boronic acid, (2',5'-dimethoxy[1,1'-biphenyl]-4-yl)-)
• 259209-22-8(2-Hydroxy-3-methylphenylboronic acid)
• 259209-31-9(Boronic acid,(2-hydroxy-3,4-dimethylphenyl)- (9CI))
• 215433-49-1((R)-(2,2'-Dimethoxy-1,1'-binaphthalene-3,3'-diyl)diboronic acid)
• 934826-20-7(4-Hydroxy-3,5-dimethylphenylboronic acid)
• 762263-66-1((4-Hydroxy-3-methylphenyl)boronic acid)